Flavour-violation in two-Higgs-doublet models

In these proceedings we review the flavour phenomenology of 2HDMs with generic Yukawa structures [1]. We first consider the quark sector and find that despite the stringent constraints from FCNC processes large effects in tauonic B decays are still possible. We then consider lepton flavour observables, show correlations between m →eg and m− →e−e+e− in the 2HDM of type III and give upper bounds on the lepton flavour violating B decay Bd →me.

SUSYFLAVOR library for rare decays in the MSSM

SUSY_FLAVOR is a FORTRAN code calculating over 30 low-energy flavour- and CP-related bservables in the R-parity conserving MSSM. The code admits for the most general flavour structure of the SUSY breaking terms and complex flavour-diagonal couplings. It includes the numerically important resummation of chirally enhanced effects and it is fast enough for scanning over a large SUSY-parameter space. The program can be obtained from http://www.fuw.edu.pl/susy_flavor.

Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.

The selection of liver transplant candidates with hepatocellular carcinoma (HCC) is currently validated based on Milan criteria. The use of extended criteria has remained a matter of debate, mainly because of the absence of prospective validation. The present prospective study recruited patients according to the previously proposed Total Tumor Volume (TTV ≤115 cm(3) )/alpha fetoprotein (AFP ≤400 ng/ml) score. Patients with AFP >400 ng/ml were excluded, and as such the Milan group was modified to include only patients with AFP <400 ng/ml; these patients were compared to patients beyond Milan, but within TTV/AFP. From January 2007 to March 2013, 233 patients with HCC were listed for liver transplantation. Of them, 195 patients were within Milan, and 38 beyond Milan but within TTV/AFP. The average follow-up from listing was 33,9 ±24,9 months. The risk of drop-out was higher for patients beyond Milan but within TTV/AFP (16/38, 42,1%), than for patients within Milan (49/195, 25,1%, p=0,033). In parallel, intent-to-treat survival from listing was lower in the patients beyond Milan (53,8% vs. 71,6% at four years, p<0,001). After a median waiting time of 8 months, 166 patients were transplanted, 134 patients within Milan criteria, and 32 beyond Milan but within TTV/AFP. They demonstrated acceptable and similar recurrence rates (4,5% vs. 9,4%, p=0,138) and post-transplant survivals (78,7% vs. 74,6% at four years, p=0,932). CONCLUSION Based on the present prospective study, HCC liver transplant candidate selection could be expanded to the TTV (≤115 cm(3) )/AFP (≤400 ng/ml) criteria in centers with at least 8-month waiting time. An increased risk of drop-out on the waiting list can be expected but with equivalent and satisfactory post-transplant survival. This article is protected by copyright. All rights reserved.